Characterization of D-17 Canine Osteosarcoma Cell Line and Evaluation of Its Ability to Response to Infective Stressor Used as Alternative Anticancer Therapy.
Paola ModestoJordi Leonardo Castrillo FernandezIsabella MartiniRoberto ZoccolaMaria Concetta PuglianoChiara Grazia De CiucisMaria GoriaAngelo FerrariElisabetta RazzuoliPublished in: Animals : an open access journal from MDPI (2020)
Osteosarcoma (OSA) is a rare cancer both in human and dog although the incidence rate in dogs is 27 times higher than in human. Many studies employed D-17 as cell line for in vitro test to evaluate conventional anticancer therapies; however, little is known about D-17 cell line. The aim of our study was to evaluate the basal level of gene expression of pivotal molecules in the innate immune response and cell cycle regulation and to establish the ability of this cell line to react to Salmonella typhimurium (ST) infective stressor. IL15, IL10, iNOS, TLR5, CD14, PTEN and IL18 were expressed in an inconsistent manner among experiments. The other genes under study were expressed in all samples. ST showed ability to penetrate D-17 causing pro-inflammatory response. Our results outline the expression in D-17 of important genes involved in innate immune response. These results provide important data on D-17 basal gene expression profile useful for in vitro preliminary evaluation of new therapeutic approaches.
Keyphrases
- immune response
- cell cycle
- inflammatory response
- gene expression
- endothelial cells
- toll like receptor
- cell proliferation
- escherichia coli
- dendritic cells
- poor prognosis
- dna methylation
- obstructive sleep apnea
- genome wide
- risk factors
- squamous cell carcinoma
- induced pluripotent stem cells
- bone marrow
- anti inflammatory
- mesenchymal stem cells
- papillary thyroid
- listeria monocytogenes
- nitric oxide
- pi k akt
- case control
- binding protein
- smoking cessation
- genome wide identification
- young adults
- cell therapy
- artificial intelligence